Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology

Journal of Thrombosis and Thrombolysis, vol. 58, no. 2, pp. 284–298

Mehmet Baysal, Elif Aksoy, Kübra Hilal Bedir, Deniz Özmen İbiş, Püsem Patır, Ufuk Demirci, Samet Yam...

2025 Hakemli SCI-Expanded Q3 Link
Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

, vol. 144, no. Supplement 1, pp. 6585–6585

Serkan Güven, Deniz Özmen İbiş, Yunuz Çatma, Tuba Güllü Koca, Hakkı Onur Kırkızlar, Ömer Şeker, Serc...

2024 Link
Impact of CALR and JAK2 V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients

Turkish Journal of Hematology, vol. 41, no. 1, pp. 26–36

Zehra Narlı Özdemir, Yıldız İpek, Püsem Patır, Gözde Ermiş, Rafiye Çiftçiler, Deniz Özmen İbiş, Mehm...

2024 Hakemli SCI-Expanded Q3 Link
Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study

Journal of Oncology Pharmacy Practice, vol. 31, no. 8, pp. 1248–1255

Rafiye Çiftçiler, Cem Selim, Melda Cömert, Haydar Zengin, Yıldız İpek, Vildan Gürsoy, Esra Yıldızhan...

2024 Hakemli SCI-Expanded Q4 Link
Current and emerging tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia in young adults

Expert Opinion on Pharmacotherapy, vol. 24, no. 15, pp. 1703–1713

Sinan Mersin, Fatih Gülük, Emirhan Gülcan, Ahmet Emre Eşkazan

2023 Hakemli SCI-Expanded Q3 Link
Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma

Indian Journal of Hematology and Blood Transfusion, vol. 39, no. 2, pp. 220–227

Ayfer Gedük, Berrin Öztaş, Baldan Huri Eryılmaz, Esra Terzi Demirsoy, Meral Mengüç, Serkan Ünal, Sin...

2022 Hakemli SCI-Expanded Q4 Link
The Evaluation of Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients

Turkish Journal of Hematology, vol. 38, no. 3, pp. 211–217

Sinan Mersin, Ayfer Gedük, Özgür Mehtap, Pınar Tarkun, Serkan Ünal, Merve Gökçen Polat, Kemal Aygün,...

2021 Hakemli SCI-Expanded Q4
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma

International Journal of Laboratory Hematology, vol. 43, no. 4, pp. 638–644

Şeyma Şumnu, Özgür Mehtap, Sinan Mersin, Tayfur Toptaş, Gözde Dağlıöz Görür, Ayfer Gedük, Serkan Üna...

2021 Hakemli SCI-Expanded Q3 14 atıf Link
Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers

Clinical and Experimental Nephrology, vol. 23, no. 4, pp. 530–536

Halil İbrahim Erdoğdu, Eray Atalay, Gül Gürsoy, Başol Canbakan, Serkan Aktürk, Canan Yazıcı, Orhan Y...

2018 Hakemli SCI-Expanded Q3 Link
IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort

Clinical Lymphoma Myeloma and Leukemia, vol. 15, no. 6, pp. e101–e104

Ömür Gökmen Sevindik, Sinan Mersin, Abdullah Katgı, Sunay Tunalı, Şerife Solmaz, Celal Acar, İnci Al...

2015 Hakemli SCI-Expanded Q3 5 atıf Link
Kronik Lenfositik Lösemide PD-1/PDL1 Ekspresyon Düzeyleri ve Prognostik Önemi

Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, vol. 12, no. 2, pp. 197–203

Ayfer Gedük, Özgür Mehtap, Elif Birtaş Ateşoğlu, Pınar Tarkun, Esra Terzi Demirsoy, Meral Uluköylü M...

2021 Hakemli TR DİZİN
Yaşlı Akut Lenfositik Lösemi Hastalarının Tedavisinde Standart Tedavi mi? Düşük Yoğunluklu Tedavi mi?

SDÜ Sağlık Bilimleri Dergisi, vol. 10, no. 3, pp. 224–229

Pınar Tarkun, Özgür Mehtap, Mengüç Meral Uluköylü, Sinan Mersin, Serkan Ünal, Ayfer Gedük, Elif Birt...

2019 Hakemli TR DİZİN Link
Diğer kategoride makale bulunamadı!